Literature DB >> 24081124

Removing the immune response from muscular dystrophy research.

Jeffrey S Chamberlain1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24081124      PMCID： PMC3808148          DOI： 10.1038/mt.2013.209

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  13 in total

1.  Dystrophin immunity in Duchenne's muscular dystrophy.

Authors:  Jerry R Mendell; Katherine Campbell; Louise Rodino-Klapac; Zarife Sahenk; Chris Shilling; Sarah Lewis; Dawn Bowles; Steven Gray; Chengwen Li; Gloria Galloway; Vinod Malik; Brian Coley; K Reed Clark; Juan Li; Xiao Xiao; Jade Samulski; Scott W McPhee; R Jude Samulski; Christopher M Walker
Journal:  N Engl J Med       Date:  2010-10-07       Impact factor: 91.245

Review 2.  Are human and mouse satellite cells really the same?

Authors:  Luisa Boldrin; Francesco Muntoni; Jennifer E Morgan
Journal:  J Histochem Cytochem       Date:  2010-07-19       Impact factor: 2.479

3.  The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy.

Authors:  I Danko; V Chapman; J A Wolff
Journal:  Pediatr Res       Date:  1992-07       Impact factor: 3.756

4.  Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.

Authors:  M J Spencer; E Montecino-Rodriguez; K Dorshkind; J G Tidball
Journal:  Clin Immunol       Date:  2001-02       Impact factor: 3.969

Review 5.  Stem and progenitor cells in skeletal muscle development, maintenance, and therapy.

Authors:  Bruno Péault; Michael Rudnicki; Yvan Torrente; Giulio Cossu; Jacques P Tremblay; Terry Partridge; Emanuela Gussoni; Louis M Kunkel; Johnny Huard
Journal:  Mol Ther       Date:  2007-03-27       Impact factor: 11.454

6.  The fate of individual myoblasts after transplantation into muscles of DMD patients.

Authors:  E Gussoni; H M Blau; L M Kunkel
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

7.  Dmd(mdx-beta geo): a new allele for the mouse dystrophin gene.

Authors:  K Wertz; E M Füchtbauer
Journal:  Dev Dyn       Date:  1998-06       Impact factor: 3.780

8.  The Rag2⁻Il2rb⁻Dmd⁻ mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies.

Authors:  Denis Vallese; Elisa Negroni; Stéphanie Duguez; Arnaud Ferry; Capucine Trollet; Ahmed Aamiri; Christian A J Vosshenrich; Ernst-Martin Füchtbauer; James P Di Santo; Libero Vitiello; Gillian Butler-Browne; Vincent Mouly
Journal:  Mol Ther       Date:  2013-08-23       Impact factor: 11.454

Review 9.  Therapeutic approaches to muscular dystrophy.

Authors:  Aurélie Goyenvalle; Jane T Seto; Kay E Davies; Jeffrey Chamberlain
Journal:  Hum Mol Genet       Date:  2011-03-24       Impact factor: 6.150

10.  Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration.

Authors:  Toshifumi Yokota; Qi-Long Lu; Jennifer E Morgan; Kay E Davies; Rosie Fisher; Shin'ichi Takeda; Terence A Partridge
Journal:  J Cell Sci       Date:  2006-06-06       Impact factor: 5.285
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.